These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 3100097
1. Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. Koren E, Puchois P, Alaupovic P, Fesmire J, Kandoussi A, Fruchart JC. Clin Chem; 1987 Jan; 33(1):38-43. PubMed ID: 3100097 [Abstract] [Full Text] [Related]
2. Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay. Koren E, Puchois P, McConathy WJ, Fesmire JD, Alaupovic P. Clin Chim Acta; 1985 Apr 15; 147(2):85-95. PubMed ID: 3921293 [Abstract] [Full Text] [Related]
3. Quantitative determination of human plasma apolipoprotein A-II by a non competitive enzyme-linked immunosorbent assay. Puchois P, Kandoussi A, Duriez P, Fruchart JC, McConathy WJ, Koren E. J Immunoassay; 1986 Apr 15; 7(4):285-307. PubMed ID: 3100579 [Abstract] [Full Text] [Related]
4. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Clin Chem; 1990 Aug 15; 36(8 Pt 1):1431-5. PubMed ID: 2117505 [Abstract] [Full Text] [Related]
8. Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma. Bekaert ED, Alaupovic P, Knight-Gibson C, Norum RA, Laux MJ, Ayrault-Jarrier M. Biochim Biophys Acta; 1992 Jun 05; 1126(1):105-13. PubMed ID: 1606170 [Abstract] [Full Text] [Related]
9. Studies on the lipid and apolipoprotein compositions of two species of apoA-I-containing lipoproteins in normolipidemic males and females. Ohta T, Hattori S, Nishiyama S, Matsuda I. J Lipid Res; 1988 Jun 05; 29(6):721-8. PubMed ID: 3139812 [Abstract] [Full Text] [Related]
12. Quantitation of apolipoprotein A-IV in human plasma using a competitive enzyme-linked immunosorbent assay. Kondo K, Allan C, Fidge N. J Lipid Res; 1989 Jun 05; 30(6):939-44. PubMed ID: 2507721 [Abstract] [Full Text] [Related]
13. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II. Clay MA, Cehic DA, Pyle DH, Rye KA, Barter PJ. Biochem J; 1999 Feb 01; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287 [Abstract] [Full Text] [Related]
15. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome. Gordon SM, Li H, Zhu X, Tso P, Reardon CA, Shah AS, Lu LJ, Davidson WS. J Proteomics; 2016 Sep 02; 146():184-94. PubMed ID: 27385375 [Abstract] [Full Text] [Related]
16. Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma. Brown SA, Rhodes CE, Dunn K, Gotto AM, Patsch W. Clin Chem; 1988 May 02; 34(5):920-4. PubMed ID: 3131044 [Abstract] [Full Text] [Related]
19. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier). Schaefer EJ, Kay LL, Zech LA, Brewer HB. J Clin Invest; 1982 Nov 02; 70(5):934-45. PubMed ID: 7130397 [Abstract] [Full Text] [Related]